$1.040
+0.042 (+4.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CVKD por análisis de gráficos similares
Alphio's CVKD stock price prediction model matches the current Cadrenal Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.00 (-4.09%). The 1-week path is $1.01 (-2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Cadrenal Therapeutics Inc?
Cadrenal Therapeutics Inc (CVKD) is currently trading at $1.04, which is significantly lower than its 52-week high of $13.01, indicating a potential for recovery. However, the stock has a low RSI of 43.865, suggesting it is not yet oversold, and the forward P/E ratio is at 0, indicating uncertainty in future earnings. The recent positive news about a $3 million private placement and a 25% reduction in thrombotic events from CAD-1005 are encouraging signs, but the company has a substantial year-to-date decline of 85.81% and negative net income figures, with the latest reported EPS at -1.14. Therefore, while there are some positive catalysts, the overall financial performance and significant risks suggest a hold position for now.
CVKD cerró en $1.04 el Friday, tras subir +4.00%
Cadrenal Therapeutics Inc (CVKD) last closed at $1.04, gaining +4.00%. These facts feed the 1-day and 1-week CVKD price prediction above.
Factores de la previsión
Los factores de la previsión de Cadrenal Therapeutics Inc (CVKD) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CVKD, ordenadas por similitud.
Análisis de estacionalidad de CVKD
Historically the probability of a positive November return for CVKD is 45.45%. January offers the highest probability of a positive month at 75.41%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CVKD
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $8.95 | $10.19 | $10.29 | +879.67% |
| Dec 2026 | $11.65 | $12.26 | $12.79 | +1078.89% |
En 2026, se proyecta que Cadrenal Therapeutics Inc (CVKD) oscile entre $8.95 y $12.79.
Previsión mensual de Cadrenal Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $10.19, con un mínimo de $8.95 y un máximo de $10.29.
En Dec de 2026, se proyecta que Cadrenal Therapeutics Inc promedie $12.26, con un mínimo de $11.65 y un máximo de $12.79.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.